- 2-4 months for primary treatment
- 2-4 weeks from radiation completion, months for full recovery
- 83%
China versus the U.S.
- China clinical rate
- $5,000 – $25,000
- $15,000
- United States
- $30,000 – $150,000
- $90,000
- You save
- ~83%
- $75,000 per procedure
Prices are approximate ranges. Actual cost depends on hospital, surgeon, materials, and case complexity.
What the procedure involves.
Nasopharyngeal carcinoma (NPC) is endemic in southern China, making Chinese oncologists the world's foremost experts in its treatment. Decades of experience with thousands of cases have refined radiation techniques (IMRT), concurrent chemotherapy protocols, and immunotherapy integration that achieve cure rates of 80-90% for early-stage disease. No other country has comparable expertise, volume, and outcomes for this specific cancer type.
Step by step.
MRI Staging & EBV Testing
Nasopharyngeal MRI, EBV DNA quantification, and PET-CT determine disease stage and prognosis
Induction Chemotherapy
Gemcitabine-cisplatin or TPF regimen reduces tumor burden before radiation
Concurrent Chemoradiation
Intensity-modulated radiation therapy (IMRT) with concurrent cisplatin — the curative backbone of treatment
Adjuvant Therapy & Monitoring
EBV DNA monitoring, immunotherapy consideration, and regular MRI/endoscopic surveillance
- World-leading expertise — China treats more NPC than any other country
- IMRT precision minimizes damage to surrounding brain and nerve structures
- 80-90% cure rate for stages I-III
- EBV DNA monitoring enables early detection of recurrence
- Radiation-induced xerostomia (dry mouth) and taste changes
- Hearing loss from radiation and cisplatin
- Cranial nerve damage in advanced cases
- Late effects including carotid stenosis and secondary cancers
Ask the AI for hospitals that handle nasopharyngeal cancer treatment.
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.